Human alveolar macrophage activation: Inhibition by forskolin but not β-adrenoceptor stimulation or phosphodiesterase inhibition
- 31 December 1988
- journal article
- Published by Elsevier in Pulmonary Pharmacology
- Vol. 1 (2) , 101-106
- https://doi.org/10.1016/s0952-0600(88)80006-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- REBOUND INCREASE IN BRONCHIAL RESPONSIVENESS AFTER TREATMENT WITH INHALED TERBUTALINEThe Lancet, 1988
- Molecular mechanisms of signal transduction in macrophagesImmunology Today, 1987
- β-agonists can depress oxidative metabolism of alveolar macrophagesInflammation Research, 1986
- The origin of airway hyperresponsivenessJournal of Allergy and Clinical Immunology, 1986
- Inhibition of human neurophil degranulation by forskolin in the presence of phosphodiesterase inhibitorsEuropean Journal of Pharmacology, 1986
- Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutalineJournal of Allergy and Clinical Immunology, 1985
- β2-adrenoceptor agonists reverse the leukotriene C4-induced release response of macrophagesEuropean Journal of Pharmacology, 1984
- STIMULATION OF ALVEOLAR MACROPHAGES IN ASTHMATIC PATIENTS AFTER LOCAL PROVOCATION TESTThe Lancet, 1983
- Prevention of macrophage tumoricidal activity by agents known to increase cellular cyclic AMPCellular Immunology, 1979
- Modulation of adenosine 3', 5'-monophosphate contents of rat peritoneal macrophages mediated by β2-adrenergic receptorsBiochemical Pharmacology, 1977